GLP-1 SM 30mg Peptides
Crafted for researchers who value exactness, this GLP-1 SM vial is prepared to support consistent, repeatable results from the first run to the last.
Primavora GLP-1 SM is a lyophilized research peptide presented in a clean, tamper-evident vial format designed for reliable laboratory handling. This unflavored, powder-style Peptide Lyophilized Vial provides a total of 30mg per unit, offering a straightforward, single-vial configuration suitable for controlled benchwork and method development.
- Each vial contains 30mg of GLP-1 SM, enabling structured in vitro or ex vivo evaluation of receptor interactions, formulation behavior, stability characteristics, and other assay-driven parameters where precision and reproducibility are required.
The lyophilized presentation supports dependable storage and reconstitution practices under established lab protocols, helping teams standardize concentrations, streamline aliquoting, and minimize run-to-run variability. The clear, professional presentation is built for methodical workflows—whether you are profiling analytical purity, mapping solubility, or establishing baseline performance for downstream assay design.
Researchers can integrate this GLP-1 SM vial into chromatography verification, identity confirmation, and cell-based assay frameworks as part of broader experimental planning. The single-vial, 30mg format simplifies inventory tracking and lot comparability, allowing teams to maintain consistent conditions across pilot studies and repeat evaluations without the complexity of multi-vial blending.
Primavora operates with a disciplined quality mindset. Each lot is identity-verified and purity-assessed using industry-standard techniques such as HPLC and mass spectrometry, with careful handling to protect integrity from receipt to fulfillment. Products are prepared and packaged in a controlled environment, with lot-level documentation available to support traceability. This material is intended strictly for laboratory research use only; it is not a drug, not for human or animal consumption, and not for diagnostic or therapeutic applications. By focusing on purity, consistency, and transparent documentation, Primavora provides a dependable USA-based source researchers can trust for high-quality peptides and related compounds.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
